China establishes VLEO industry alliance as satellites demonstrate sustained low-orbit operations China has established a ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

A study has offered new insight into what could be causing the extended lifespans of some tropical butterfly species, and the ...

The Exile are among America’s mere handful of deathrock buzz bands. After four years of climbing the live ladder and ...

I wanted beautiful macro product photos and videos for a CNET feature. Here's a behind-the-scenes look at how I got them.

Many proteins in the body are known to cause disease but remain stubbornly out of reach for the traditional ways of drugging a target. Parabilis Medicines has developed a new therapeutic modality to ...

Parabilis will use the funds to progress its first-in-class asset, zolucatetide, into a registrational trial for the treatment of desmoid tumours. Credit: good render / Shutterstock.com. Parabilis ...

Streaming is becoming more popular every day, with content creators gaining mass followings and fame seemingly overnight. Gamers are some of the top-performing streamers, so it's natural for some ...

Parabilis Medicines researchers at work. The developer of drugs and antibody-drug conjugates targeting historically undruggable protein targets and based on stabilized helical peptides or Helicons™, ...

Are you having trouble getting Windows to sleep or turn off your screens while your virtual audio mixer (BEACN, Voicemeeter, GoXLR, or Wave Link) is open? SAMISH is a lightweight, open-source utility ...

With the ink barely dry on an antibody-drug conjugate-style deal with Regeneron, Parabilis Medicines has now turned its attention to the public markets. The Massachusetts biotech, formerly known as ...

Two Parabilis Medicines researchers at work. Regeneron Pharmaceuticals will partner with Parabilis to discover and develop an initial five candidates encompassing a new form of antibody-drug ...